BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants With Inadequate Response to C5 Inhibitor Therapy
Clinical trial NCT05116774 · TERMINATED
Trial details
- NCT number
- NCT05116774
- Sponsor
- BioCryst Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-06
- Primary completion
- 2023-09-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.